Home / Industry / Pharmaceuticals & Biotechnology / Neurological Biomarkers Market

Neurological Biomarkers Market

Neurological Biomarkers Market Insights, Competitive Landscape, and Market Forecast - 2033

Published Date: May 2026 | Format: | No. of Pages: 186

Industry: Pharmaceuticals & Biotechnology | Author Name: Sayali

Request Sample / Information

  
$4,995.00
Buy now
Report Description Research Methodology

FAQ : Neurological Biomarkers Market

The Neurological Biomarkers Market is valued at USD 9.4 Bn in 2026.

The Neurological Biomarkers Market is projected to grow at a CAGR of 10% by 2033.

The market growth is driven by rising neurological disorders, increasing depression cases, and growing adoption of personalized medicine.

North America is a dominating region for the neurological biomarkers market.

Abbott, Thermo Fisher Scientific, Inc., Merck & Co., Inc., Bio-Rad Laboratories, Inc., and Johnson & Johnson Services, Inc. are some leading industry players in the neurological biomarkers market.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services